Avantor, Inc. (AVTR)
15.44
-0.38
(-2.37%)
USD |
NYSE |
Oct 06, 16:00
15.48
+0.04
(+0.29%)
After-Hours: 20:00
Avantor EPS Diluted (Quarterly) : 0.0563 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0563 |
| March 31, 2026 | 0.064 |
| December 31, 2025 | 0.0771 |
| September 30, 2025 | -1.044 |
| June 30, 2025 | 0.0949 |
| March 31, 2025 | 0.0945 |
| December 31, 2024 | 0.733 |
| September 30, 2024 | 0.0846 |
| June 30, 2024 | 0.1361 |
| March 31, 2024 | 0.0886 |
| December 31, 2023 | 0.145 |
| September 30, 2023 | 0.1598 |
| June 30, 2023 | -0.0108 |
| March 31, 2023 | 0.1792 |
| December 31, 2022 | 0.2093 |
| September 30, 2022 | 0.2458 |
| June 30, 2022 | 0.2636 |
| March 31, 2022 | 0.2558 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.1257 |
| September 30, 2021 | 0.2352 |
| June 30, 2021 | 0.2396 |
| March 31, 2021 | 0.2511 |
| December 31, 2020 | 0.0603 |
| September 30, 2020 | -0.101 |
| June 30, 2020 | 0.0756 |
| March 31, 2020 | 0.0532 |
| December 31, 2019 | 0.0936 |
| September 30, 2019 | 0.0098 |
| June 30, 2019 | -0.5578 |
| March 31, 2019 | -0.146 |
| December 31, 2018 | -0.2328 |
| September 30, 2018 | -0.0644 |
| June 30, 2018 | -0.1742 |
| March 31, 2018 | -0.1956 |
| December 31, 2017 | -0.7627 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Medpace Holdings, Inc. | 4.250 |
| Champions Oncology, Inc. | -0.0306 |
| Personalis, Inc. | -0.3005 |
| Adaptive Biotechnologies Corp. | -0.2489 |
| 10X Genomics, Inc. | -0.138 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 38.10M |
| Revenue (Quarterly) | 1.692B |
| Total Expenses (Quarterly) | 1.654B |
| Enterprise Value | 14.09B |
| Gross Profit Margin (Quarterly) | 31.73% |
| Profit Margin (Quarterly) | 2.25% |
| Earnings Yield | -5.49% |
| Operating Earnings Yield | 5.14% |
| Normalized Earnings Yield | 0.0544 |